← Back to patent-cliff list
CAS 63618-91-7
(2E,2'E)-2,2'-(butane-2,3-diylidene)bis(N-methylhydrazine-1-carbothioamide)
Codes: Cu(II)ATSM-005
Application context (from source-drug indications)
Rectal cancerCu(II)ATSMCervical cancerCu(II)ATSMParkinson's diseaseCu(II)ATSM运动神经元病Cu(II)ATSMAmyotrophic lateral sclerosisCu(II)ATSM
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Cu(II)ATSM | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Cu(II)ATSM→N-methylhydrazinecarbothioamide→3,3-dimethoxybutan-2-one→(E)-2-(3,3-dimethoxybutan-2-ylidene)-N-methylhydrazine-1-carbothioamide→(E)-N-methyl-2-(3-oxobutan-2-ylidene)hydrazine-1-carbothioamide→(2E,2'E)-2,2'-(butane-2,3-diylidene)bis(N-methylhydrazine-1-carbothioamide)
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.